Hologic, Inc. (0J5Q.L)
USD 53.0
(-7.67%)
USD 53.0
(-7.67%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 4.03 Billion USD | -0.0% |
| 2023 | 4.03 Billion USD | -17.12% |
| 2022 | 4.86 Billion USD | -13.66% |
| 2021 | 5.63 Billion USD | 49.14% |
| 2020 | 3.77 Billion USD | 12.15% |
| 2019 | 3.36 Billion USD | 4.64% |
| 2018 | 3.21 Billion USD | 5.2% |
| 2017 | 3.05 Billion USD | 7.98% |
| 2016 | 2.83 Billion USD | 4.72% |
| 2015 | 2.7 Billion USD | 6.89% |
| 2014 | 2.53 Billion USD | 1.54% |
| 2013 | 2.49 Billion USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 1.01 Billion USD | 7.17% |
| 2024 Q2 | 1.01 Billion USD | 0.46% |
| 2024 Q3 | 1.01 Billion USD | -0.63% |
| 2024 Q4 | 987.9 Million USD | -2.32% |
| 2023 FY | 4.03 Billion USD | -17.12% |
| 2023 Q2 | 1.02 Billion USD | -4.44% |
| 2023 Q1 | 1.07 Billion USD | 12.68% |
| 2023 Q4 | 945.3 Million USD | -3.97% |
| 2023 Q3 | 984.4 Million USD | -4.1% |
| 2022 Q1 | 1.47 Billion USD | 11.73% |
| 2022 FY | 4.86 Billion USD | -13.66% |
| 2022 Q4 | 953.3 Million USD | -4.93% |
| 2022 Q3 | 1 Billion USD | -30.16% |
| 2022 Q2 | 1.43 Billion USD | -2.41% |
| 2021 FY | 5.63 Billion USD | 49.14% |
| 2021 Q3 | 1.16 Billion USD | -24.02% |
| 2021 Q4 | 1.31 Billion USD | 12.69% |
| 2021 Q1 | 1.6 Billion USD | 19.52% |
| 2021 Q2 | 1.53 Billion USD | -4.49% |
| 2020 Q3 | 822.9 Million USD | 8.83% |
| 2020 Q4 | 1.34 Billion USD | 63.68% |
| 2020 FY | 3.77 Billion USD | 12.15% |
| 2020 Q1 | 850.5 Million USD | -1.78% |
| 2020 Q2 | 756.1 Million USD | -11.1% |
| 2019 FY | 3.36 Billion USD | 4.64% |
| 2019 Q4 | 865.9 Million USD | 1.58% |
| 2019 Q3 | 852.4 Million USD | 4.15% |
| 2019 Q1 | 830.7 Million USD | 2.13% |
| 2019 Q2 | 818.4 Million USD | -1.48% |
| 2018 Q2 | 789.3 Million USD | -0.23% |
| 2018 Q3 | 824 Million USD | 4.4% |
| 2018 Q4 | 813.4 Million USD | -1.29% |
| 2018 FY | 3.21 Billion USD | 5.2% |
| 2018 Q1 | 791.1 Million USD | -1.47% |
| 2017 Q2 | 715.4 Million USD | -2.59% |
| 2017 FY | 3.05 Billion USD | 7.98% |
| 2017 Q3 | 806.1 Million USD | 12.68% |
| 2017 Q1 | 734.4 Million USD | 1.03% |
| 2017 Q4 | 802.9 Million USD | -0.4% |
| 2016 Q4 | 726.9 Million USD | 1.32% |
| 2016 Q1 | 695.2 Million USD | -1.08% |
| 2016 Q2 | 693.3 Million USD | -0.27% |
| 2016 Q3 | 717.4 Million USD | 3.48% |
| 2016 FY | 2.83 Billion USD | 4.72% |
| 2015 Q4 | 702.8 Million USD | 1.28% |
| 2015 FY | 2.7 Billion USD | 6.89% |
| 2015 Q2 | 655.5 Million USD | 0.41% |
| 2015 Q1 | 652.8 Million USD | 2.21% |
| 2015 Q3 | 693.9 Million USD | 5.86% |
| 2014 Q1 | 612.5 Million USD | 1.01% |
| 2014 FY | 2.53 Billion USD | 1.54% |
| 2014 Q3 | 632.6 Million USD | 1.22% |
| 2014 Q2 | 625 Million USD | 2.04% |
| 2014 Q4 | 638.7 Million USD | 0.96% |
| 2013 Q1 | 631.36 Million USD | 0.0% |
| 2013 Q4 | 606.4 Million USD | -3.15% |
| 2013 Q3 | 626.1 Million USD | 2.19% |
| 2013 Q2 | 612.66 Million USD | -2.96% |
| 2013 FY | 2.49 Billion USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Phreesia, Inc. | 356.29 Million USD | -1031.157% |
| Accuray Incorporated | 446.55 Million USD | -802.54% |
| Align Technology, Inc. | 3.86 Billion USD | -4.351% |
| Elevance Health Inc. | 171.34 Billion USD | 97.648% |
| AxoGen, Inc. | 159.01 Million USD | -2434.589% |
| Boston Scientific Corporation | 14.24 Billion USD | 71.697% |
| CVS Health Corporation | 357.77 Billion USD | 98.874% |
| Cardinal Health, Inc. | 226.82 Billion USD | 98.223% |
| Centene Corporation | 141.26 Billion USD | 97.147% |
| DaVita Inc. | 12.14 Billion USD | 66.802% |
| HCA Healthcare, Inc. | 64.96 Billion USD | 93.796% |
| Humana Inc. | 106.37 Billion USD | 96.211% |
| IDEXX Laboratories, Inc. | 3.66 Billion USD | -10.089% |
| Laboratory Corporation of America Holdings | 12.16 Billion USD | 66.86% |
| Masimo Corporation | 2.04 Billion USD | -96.782% |
| McKesson Corporation | 308.95 Billion USD | 98.695% |
| Patterson Companies, Inc. | 6.56 Billion USD | 38.64% |
| Quest Diagnostics Incorporated | 9.25 Billion USD | 56.439% |
| ResMed Inc. | 4.68 Billion USD | 13.98% |
| Henry Schein, Inc. | 12.33 Billion USD | 67.337% |
| Teladoc Health, Inc. | 2.6 Billion USD | -54.868% |
| Universal Health Services, Inc. | 14.28 Billion USD | 71.781% |
| Veeva Systems Inc. | 2.36 Billion USD | -70.51% |
| Baxter International Inc. | 14.81 Billion USD | 72.792% |
| Becton, Dickinson and Company | 19.37 Billion USD | 79.195% |
| Intuitive Surgical, Inc. | 7.12 Billion USD | 43.427% |
| Danaher Corporation | 23.89 Billion USD | 83.13% |
| Stryker Corporation | 20.49 Billion USD | 80.338% |
| Medtronic plc | 32.36 Billion USD | 87.547% |